Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.39 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4721742 | 1.00 | SLC22A6 (0.62) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL5437765 | 1.00 | SLC22A6 (0.62) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL19331126 | 0.87 | SLC22A6 (0.50) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL6629736 | 0.87 | SLC22A6 (0.50) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL705762 | 0.87 | SLC22A6 (0.50) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL13062507 | 0.87 | SLC22A6 (0.50) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL15908059 | 0.86 | — | — | |
| SCHEMBL26138078 | 0.86 | SLC22A6 (0.56) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL1032574 | 0.86 | SLC22A6 (0.56) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL15803676 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0165787-B1 | METHOD AND COMPOSITION FOR ACIDIZING SUBTERRANEAN FORMATIONS | HALLIBURTON COMPANY (US) | 1989-06-14 | — | — | EP | claimed |
| EP-0165787-A2 | Method and composition for acidizing subterranean formations | HALLIBURTON COMPANY (US) | 1985-12-27 | — | — | EP | claimed |
| US-4552672-A | ACETYLENIC ALCOHOL, ANTIMONY COMPOUND, CORROSION RESISTANCE | HALLIBURTON COMPANY (US) | 1985-11-12 | — | — | US | claimed |
| US-20170152347-A1 | AMIDE DENDRIMER COMPOSITIONS | GENZYME CORP (US) | 2017-06-01 | — | — | US | disclosed |
| US-20170152347-A1 | AMIDE DENDRIMER COMPOSITIONS | GENZYME CORP (US) | 2017-06-01 | — | — | US | disclosed |
| US-20150321996-A1 | AMIDE DENDRIMER COMPOSITIONS | GENZYME CORPORATION | 2015-11-12 | — | — | US | disclosed |
| US-20150321996-A1 | AMIDE DENDRIMER COMPOSITIONS | GENZYME CORPORATION | 2015-11-12 | — | — | US | disclosed |
| US-9066972-B2 | Amide dendrimer compositions | GENZYME CORPORATION (US) | 2015-06-30 | — | — | US | disclosed |
| US-9066972-B2 | Amide dendrimer compositions | GENZYME CORPORATION (US) | 2015-06-30 | — | — | US | disclosed |
| US-8900560-B2 | Amide dendrimer compositions | GENZYME CORPORATION (US) | 2014-12-02 | — | — | US | disclosed |
| US-8900560-B2 | Amide dendrimer compositions | GENZYME CORPORATION (US) | 2014-12-02 | — | — | US | disclosed |
| EP-0408255-A1 | Thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-01-16 | — | — | EP | disclosed |
| EP-0403056-A2 | Thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-12-19 | — | — | EP | disclosed |
| EP-0394016-A2 | Resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0391733-A2 | Thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-10-10 | — | — | EP | disclosed |
| EP-0382548-A2 | Thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-08-16 | — | — | EP | disclosed |
| EP-0381391-A2 | Resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-08-08 | — | — | EP | disclosed |
| EP-0165787-B1 | METHOD AND COMPOSITION FOR ACIDIZING SUBTERRANEAN FORMATIONS | HALLIBURTON COMPANY (US) | 1989-06-14 | — | — | EP | disclosed |
| EP-0165787-A2 | Method and composition for acidizing subterranean formations | HALLIBURTON COMPANY (US) | 1985-12-27 | — | — | EP | disclosed |
| US-4552672-A | ACETYLENIC ALCOHOL, ANTIMONY COMPOUND, CORROSION RESISTANCE | HALLIBURTON COMPANY (US) | 1985-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150321996-A1 | AMIDE DENDRIMER COMPOSITIONS | FABP2, PHOSPHO1, PAM | SLC22A6 1566/4885SMN1; SMN2 4083/4885GABRR1 2167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.